32.00
-1.01 (-3.06%)
| Penutupan Terdahulu | 33.01 |
| Buka | 32.10 |
| Jumlah Dagangan | 3,229,320 |
| Purata Dagangan (3B) | 933,114 |
| Modal Pasaran | 1,475,913,216 |
| Harga / Pendapatan (P/E Ke hadapan) | 86.96 |
| Harga / Jualan (P/S) | 7.44 |
| Harga / Buku (P/B) | 14.41 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 29 Oct 2025 |
| Margin Keuntungan | -3.68% |
| Margin Operasi (TTM) | -3.42% |
| EPS Cair (TTM) | -0.160 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 17.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 67.39% |
| Nisbah Semasa (MRQ) | 4.28 |
| Aliran Tunai Operasi (OCF TTM) | 3.62 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 2.84 M |
| Pulangan Atas Aset (ROA TTM) | -0.13% |
| Pulangan Atas Ekuiti (ROE TTM) | -7.22% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | AxoGen, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 1.38 |
|
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 4.84% |
| % Dimiliki oleh Institusi | 86.20% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| First Light Asset Management, Llc | 30 Sep 2025 | 5,805,730 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 40.00 (Mizuho, 25.00%) | Beli |
| 40.00 (Lake Street, 25.00%) | Beli | |
| Median | 37.00 (15.63%) | |
| Rendah | 27.00 (Raymond James, -15.63%) | Beli |
| Purata | 36.14 (12.94%) | |
| Jumlah | 7 Beli | |
| Harga Purata @ Panggilan | 29.46 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Canaccord Genuity | 05 Dec 2025 | 37.00 (15.63%) | Beli | 33.32 |
| 30 Oct 2025 | 27.00 (-15.63%) | Beli | 22.68 | |
| HC Wainwright & Co. | 05 Dec 2025 | 39.00 (21.88%) | Beli | 33.32 |
| 30 Oct 2025 | 26.00 (-18.75%) | Beli | 22.68 | |
| Jefferies | 04 Dec 2025 | 36.00 (12.50%) | Beli | 32.86 |
| Lake Street | 04 Dec 2025 | 40.00 (25.00%) | Beli | 32.86 |
| Mizuho | 01 Dec 2025 | 40.00 (25.00%) | Beli | 28.53 |
| Citizens | 30 Oct 2025 | 34.00 (6.25%) | Beli | 22.68 |
| Raymond James | 30 Oct 2025 | 27.00 (-15.63%) | Beli | 22.68 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 21 Jan 2026 | Pengumuman | Axogen Announces Proposed Public Offering of Common Stock |
| 21 Jan 2026 | Pengumuman | Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock |
| 12 Jan 2026 | Pengumuman | Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025 |
| 17 Dec 2025 | Pengumuman | Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference |
| 03 Dec 2025 | Pengumuman | Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx) |
| 04 Nov 2025 | Pengumuman | Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences |
| 29 Oct 2025 | Pengumuman | Axogen, Inc. Reports Third Quarter 2025 Financial Results |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |